ArticleImmunology2016

CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation.

Daniel Perez-Witzke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.